Pfizer has won approval in the European Union to start marketing a chewable version of their anti-cholesterol drug Lipitor to children as young as 10. Pfizer has already won U.S. approval for Lipitor use in children 10 to 17 with that condition in 2002.
EU Approves Pfizer Cholesterol Drug for children
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment